Literature DB >> 19764821

Cob(I)alamin for trapping butadiene epoxides in metabolism with rat S9 and for determining associated kinetic parameters.

Hitesh V Motwani1, Charlotta Fred, Johanna Haglund, Bernard T Golding, Margareta Törnqvist.   

Abstract

The reduced state of vitamin B(12), cob(I)alamin, acts as a supernucleophile that reacts ca. 10(5) times faster than standard nucleophiles, for example, thiols. Methods have been developed for trapping electrophilically reactive compounds by exploiting this property of cob(I)alamin. 1,3-Butadiene (BD) has recently been classified as a group 1 human carcinogen by the International Agency for Research on Cancer (IARC). The carcinogenicity of BD is considered to be dependent on the activation or deactivation of the reactive metabolites of BD, that is, the epoxides (oxiranes) 1,2-epoxy-3-butene (EB), 1,2:3,4-diepoxybutane (DEB), and 1,2-epoxy-3,4-butanediol (EBdiol). Cytochrome P450 (P450) isozymes are involved in oxidation of BD to EB and further activation to DEB. EB and DEB are hydrolyzed by epoxide hydrolases (EH) to 3,4-dihydroxy-1-butene (BDdiol) and EBdiol, respectively. EBdiol can also be formed by oxidation of BDdiol. In the present study, cob(I)alamin was used for instant trapping of the BD epoxide metabolites generated in in vitro metabolism to study enzyme kinetics. The substrates EB, DEB, and BDdiol were incubated with rat S9 liver fraction, and apparent K(m) and apparent V(max), were determined. The ratio of conversion of EB to DEB (by P450) to the rate of deactivation of DEB by EH was 1.09. Formation of EBdiol from hydrolysis of DEB was ca. 10 times faster than that from oxidation of BDdiol. It was also found that the oxidation of EB to DEB was much faster than that of BDdiol to EBdiol. The study offers comparative enzyme kinetic data of different BD metabolic steps, which is useful for quantitative interspecies comparison. Furthermore, a new application of cob(I)alamin was demonstrated for the measurement of enzyme kinetics of compounds that form electophilically reactive metabolites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764821     DOI: 10.1021/tx900088w

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  Kinetics and mechanism of oxidation of super-reduced cobalamin and cobinamide species by thiosulfate, sulfite and dithionite.

Authors:  Ilia A Dereven'kov; Denis S Salnikov; Sergei V Makarov; Gerry R Boss; Oskar I Koifman
Journal:  Dalton Trans       Date:  2013-11-21       Impact factor: 4.390

2.  Comparative studies of reaction of cobalamin (II) and cobinamide (II) with sulfur dioxide.

Authors:  Ilia A Dereven'kov; Pavel A Ivlev; Cristina Bischin; Denis S Salnikov; Radu Silaghi-Dumitrescu; Sergei V Makarov; Oscar I Koifman
Journal:  J Biol Inorg Chem       Date:  2017-06-15       Impact factor: 3.358

3.  Molecular basis of cobalamin-dependent RNA modification.

Authors:  Daniel P Dowling; Zachary D Miles; Caroline Köhrer; Stephanie J Maiocco; Sean J Elliott; Vahe Bandarian; Catherine L Drennan
Journal:  Nucleic Acids Res       Date:  2016-09-15       Impact factor: 16.971

Review 4.  Learning from B12 enzymes: biomimetic and bioinspired catalysts for eco-friendly organic synthesis.

Authors:  Keishiro Tahara; Ling Pan; Toshikazu Ono; Yoshio Hisaeda
Journal:  Beilstein J Org Chem       Date:  2018-10-02       Impact factor: 2.883

Review 5.  The expanding role of electrospray ionization mass spectrometry for probing reactive intermediates in solution.

Authors:  Weitao Zhu; Yu Yuan; Peng Zhou; Le Zeng; Hua Wang; Ling Tang; Bin Guo; Bo Chen
Journal:  Molecules       Date:  2012-09-27       Impact factor: 4.411

6.  Parallelogram based approach for in vivo dose estimation of genotoxic metabolites in humans with relevance to reduction of animal experiments.

Authors:  Hitesh V Motwani; Cecilia Frostne; Margareta Törnqvist
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.